1. Historical perspectives on psychosis risk CRISTINA MEI AND PATRICK D. MCGORRY 2. Principles of risk, screening, and prevention in psychiatry EMMA SONESON, JESUS PEREZ, AND PETER B. JONES I - Risk paradigms 3. At-risk mental states ALISON R. YUNG 4. Subjective disturbances in emerging psychosis: basic symptoms and self-disturbances FRAUKE SCHULTZE-LUTTER, CHANTAL MICHEL, RAHEL FL €UCKIGER, AND ANASTASIA THEODORIDOU 5. Schizotypy, schizotypal personality, and psychosis risk NEUS BARRANTES-VIDAL, ANNA RACIOPPI, AND THOMAS R. KWAPIL 6. Familial high risk and high-risk studies LIANA ROMANIUK, STELLA W.Y. CHAN, ALIX MACDONALD, JESSIKA E. SUSSMANN, ANDREW M. MCINTOSH, HEATHER C. WHALLEY, AND STEPHEN M. LAWRIE 7. Psychotic-like experiences in the general population COLM HEALY AND MARY CANNON 8. 22q11.2 deletion syndrome: a neurodevelopmental model of psychosis CORRADO SANDINI, STEPHAN ELIEZ, MAUDE SCHNEIDER, AND MARCO ARMANDO II - Specific areas and risk 9. Neuroimaging studies in people at clinical high risk for psychosis GEORGE GIFFORD, ROB MCCUTCHEON, AND PHILIP MCGUIRE 10. Genetic studies of psychosis HANNAH J. JONES, STANLEY ZAMMIT, AND JAMES T.R. WALTERS 11. Immune processes and risk of psychosis ADAM AL-DIWANI AND THOMAS ARTHUR NICHOLLS POLLAK 12. Neurochemical models of psychosis risk and onset DOMINIC OLIVER, GEMMA MODINOS, AND PHILIP MCGUIRE 13. Clinical risk factors for psychosis ASWIN RATHEESH, JESSICA A. HARTMANN, AND BARNABY NELSON 14. Cognitive risk factors for psychosis KELLY ALLOTT AND ASHLEIGH LIN 15. Society and risk of psychosis CRAIG MORGAN, TESSA ROBERTS, BRIAN O. DONOGHUE, AND ANDREW THOMPSON 16. Is there sufficient evidence that cannabis use is a risk factor for psychosis? MARCO COLIZZI AND SAGNIK BHATTACHARYYA III - Interventions 17. The ethics of identifying and treating psychosis risk PAOLO CORSICO AND ILINA SINGH JEAN ADDINGTON, DANIJELA PISKULIC, DANIEL J. DEVOE, OLGA SANTESTEBAN-ECHARRI, AND JACQUELINE STOWKOWY 19. Pharmacological intervention for people at risk of psychotic disorder E. BURKHARDT, K. LEOPOLD AND A. BECHDOLF 20. International services for assessing and treating psychosis risk CHRISTY L.M. HUI, W.C. CHANG, SHERRY K.W. CHAN, EDWIN H.M. LEE, Y.N. SUEN, AND ERIC Y.H. CHEN 21. New paradigms to study psychosis risk: clinical staging, pluripotency, and dynamic prediction RACHAEL SPOONER, JESSICA A. HARTMANN, PATRICK D. MCGORRY, AND BARNABY NELSON 22. Future directions in risk research NIKOLAI ALBERT, LOUISE BIRKEDAL GLENTHØJ, AND MERETE NORDENTOFT
Dr Andrew Thompson is a Principal Research Fellow and Associate
Professor at Orygen, the Centre for Youth Mental Health at the
University of Melbourne, Australia. He is the lead psychiatrist for
the EPPIC early psychosis service and the National headspace Early
Psychosis program in Australia and is currently head of clinical
psychosis research at Orygen. He also retains a position as
Associate Professor at the University of Warwick in the UK.
Andrew trained in medicine at the University of Oxford and London
and in psychiatry in Nottingham and Bristol. He has an MD in
clinical psychiatry from the University of London. He has worked in
early psychosis practice and research for over 15 years in both the
UK and Australia. He was previously clinical lead for the PACE at
risk for psychosis clinic in Melbourne and has been involved in a
number of research projects through this clinic and through his
work at the University of Bristol and the University of
Warwick.
Andrew’s research interests include clinical risk factors for the
development of psychosis and psychotic symptoms, novel treatments
(including technology) in emerging or early psychosis, predictors
of outcome in early psychosis and systems of care and prevention
approaches in youth mental health. Dr Matthew Broome is a Senior
Clinical Research Fellow at the Department of Psychiatry,
University of Oxford, and a Consultant Psychiatrist at the Early
Intervention in Psychosis Service, Oxford. He trained in medicine
at the University of Birmingham and in Psychiatry at the Maudsley
hospital (where he worked at the at risk for psychosis clinic
(OASIS). He has previously been a Lecturer at the Institute of
Psychiatry and an Associate Clinical Professor at The University of
Warwick. He has previously edited books on subjects such as
phenomenology and the interface between psychiatry and philosophy
and has published over 100 research papers mostly relating to at
risk for psychosis groups.
Ask a Question About this Product More... |